Home › Cancer (all types) › California
Cancer (all types) clinical trials in California
172 studies for Cancer (all types) are looking for participants at sites in California.
Cities in California
- Los Angeles73 studies
- San Francisco38 studies
- Mountain View38 studies
- Baldwin Park34 studies
- San Diego31 studies
- Santa Monica21 studies
- Irvine18 studies
- Orange15 studies
- Sacramento11 studies
- Santa Rosa10 studies
- Santa Barbara7 studies
- Concord7 studies
- San Jose6 studies
- Huntington Beach6 studies
- Newport Beach6 studies
- Long Beach6 studies
- Vallejo5 studies
- Fullerton5 studies
- Glendale5 studies
- Fresno4 studies
- Oakland4 studies
- Roseville4 studies
- Richmond4 studies
- Bakersfield4 studies
- Pleasanton3 studies
- Santa Clara3 studies
- Modesto3 studies
- Sunnyvale3 studies
- Mission Viejo3 studies
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Sansum Clinic, Santa Barbara
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Nov 13, 2026 · NCT05920356Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
- City of Hope Medical Center, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07672769Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
- Glendale Adventist Medical Center d/b/a Adventist Health Glendale, Glendale
Recruiting
Ages 70 and older · All sexes · Updated Nov 12, 2026 · NCT07629206A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
- The City of Hope National Medical Center, Duarte
- Hoag Memorial Hospital, Newport Beach
RecruitingPhase 1
Ages 16 and older · All sexes · Updated Nov 12, 2026 · NCT07197554RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 10, 2026 · NCT07002034Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Kaiser Permanente-Deer Valley Medical Center, Antioch
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- Sutter Auburn Faith Hospital, Auburn
- and 87 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06580314Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Keck Medicine of USC, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
- Sutter Health, San Francisco
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07195591A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Providence Medical Group, Santa Rosa
RecruitingPhase 1
Ages 18 to 99 · All sexes · Updated Nov 6, 2026 · NCT06983743Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Oncura Health, Glendale
- UC San Diego Health - Moores Cancer Center, La Jolla
- California Research Institute, Los Angeles
- and 4 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT04198766A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- CBCC Global Research - Comprehensive Blood & Cancer Center, Bakersfield
- TOI Clinical Research, Cerritos
- University of California, San Diego Moores Cancer Center, La Jolla
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06901531COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship Care
- Stanford University, Palo Alto
RecruitingHealthy volunteers welcome
Ages 18 to 25 · All sexes · Updated Nov 4, 2026 · NCT07606443A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- Marin Cancer Care, Greenbrae
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
- Cancer and Blood Specialty Clinic, Los Alamitos
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07169851A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- City of Hope, Duarte
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06150157Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- and 10 more
Recruiting
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07059884A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Cedars-Sinai Medical Center, Los Angeles
- BASS Cancer Center, Walnut Creek
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06119581Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- City Of Hope, Duarte
- University Of California San Diego Moores Cancer Center, La Jolla
- University of California, San Francisco- California, San Francisco
- and 2 more
RecruitingPhase 2/3
All ages · All sexes · Updated Nov 2, 2026 · NCT03435796A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
- University of California San Diego Moores Cancer Center, La Jolla
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT06010329A Study of ARC-02 in B-cell NHL
- Start Cala, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07691606A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
- GSK Investigational Site, La Jolla
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT06796907A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Children's Hospital Los Angeles ( Site 4006), Los Angeles
RecruitingPhase 1/2
1 Month – 17 Years · All sexes · Updated Oct 30, 2026 · NCT07630974Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- City of Hope Comprehensive Cancer Center, Duarte
- University of California, Irvine, Irvine
- USC Norris Comprehensive Cancer Center, Los Angeles
- and 2 more
RecruitingPhase 3
Ages 18 to 71 · All sexes · Updated Oct 30, 2026 · NCT07504458Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
- University of California, Los Angeles (Data or Specimen Analysis Only), Los Angeles
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07030686A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- City of Hope /ID# 243157, Duarte
- City Of Hope - Seacliff /ID# 263143, Huntington Beach
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 263144, Irvine
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT04928846A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- UCLA Santa Monica Hematology Oncology, Santa Monica
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07094204Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Children's Hospital Los Angeles, Los Angeles
RecruitingPhase 2
Ages 1 to 26 · All sexes · Updated Oct 28, 2026 · NCT07680439Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Samsun Clinic - Ridley-Tree Cancer Center, Santa Barbara
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07566156A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- City Of Hope Comprehensive Cancer Center /ID# 281939, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07744126Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
- OPN Healthcare, Inc., Glendale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT05168566Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Duarte Cancer Center, Duarte
- University of California Irvine, Irvine
- Lennar Foundation Cancer Center, Irvine
- and 3 more
RecruitingPhase 1
Ages 18 and older · Men · Updated Oct 27, 2026 · NCT05997615A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- University of Southern California /ID# 272414, Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06953960A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
- Adventist Health Glendale, Glendale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06010342Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- University of California San Diego, La Jolla
- Stanford University, Palo Alto
- UCLA Medical Center, Santa Monica
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT04981119Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- VA Long Beach Healthcare System, Long Beach, CA, Long Beach
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles
Recruiting
Ages 18 and older · All sexes · Updated Oct 23, 2026 · NCT02984761ChangeGradients: Promoting Adolescent Health Behavior Change
- University of California San Francisco Adolescent and Young Adult Medicine Clinic, San Francisco
RecruitingHealthy volunteers welcome
Ages 15 to 17 · All sexes · Updated Oct 22, 2026 · NCT04110756Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- University of California, San Francisco, San Francisco
RecruitingPhase 2
Ages 2 to 99 · All sexes · Updated Oct 21, 2026 · NCT05783323Intratumoral N17350 in Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
- UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
- Scripps Clinic Torrey Pines - La Jolla, San Diego
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT07339176A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- University of California San Francisco, San Francisco
RecruitingPhase 1
Ages 18 and older · Men · Updated Oct 20, 2026 · NCT07103018Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- City of Hope Duarte, Duarte
- University of California at Los Angeles, Santa Monica
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT07529808A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
- City of Hope National Medical Center /ID# 280273, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067, Irvine
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT07409246Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
- Jonsson Comprehensive Cancer Center, Los Angeles
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT02280161From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.